Israeli cannabis producer Intercure has applied to have its stock listed on the Nasdaq. The stock is currently listed on the Toronto Stock Exchange under the ticker symbol "INCR:U" and on the Tel Aviv Stock Exchange under the ticker symbol "INCR." If accepted, the stock will trade on the Nasdaq under the same symbol.
We'll update this page as new information becomes available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.62 |
|---|---|
| 52-week range | $0.99 - $3.72 |
| 50-day moving average | $2.61 |
| 200-day moving average | $1.91 |
| Wall St. target price | $32.91 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.36 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.62 from 2024-07-23
| 1 week (2024-07-18) | 14.91% |
|---|---|
| 1 month (2024-06-25) | 20.18% |
| 3 months (2024-04-25) | -0.76% |
| 6 months (2024-01-25) | 114.75% |
| 1 year (2023-07-25) | 65.82% |
|---|---|
| 2 years (2022-07-25) | -57.26% |
| 3 years (2021-07-23) | 6.25 |
| 5 years (2019-07-24) | 43.96% |
Valuing Intercure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Intercure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Intercure's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.7 million.
The EBITDA is a measure of a Intercure's overall financial performance and is widely used to measure a its profitability.
To put Intercure's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $355.6 million |
|---|---|
| Gross profit TTM | $102.6 million |
| Return on assets TTM | -0.11% |
| Return on equity TTM | -12.99% |
| Profit margin | -17.43% |
| Book value | $9.99 |
| Market Capitalization | $104.8 million |
TTM: trailing 12 months
We're not expecting Intercure to pay a dividend over the next 12 months.
Intercure's shares were split on a 877:3902 basis on 8 April 2021. So if you had owned 3902 shares the day before before the split, the next day you'd have owned 877 shares. This wouldn't directly have changed the overall worth of your Intercure shares – just the quantity. However, indirectly, the new 344.9% higher share price could have impacted the market appetite for Intercure shares which in turn could have impacted Intercure's share price.
Over the last 12 months, Intercure's shares have ranged in value from as little as $0.99 up to $3.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intercure's is 0.05. This would suggest that Intercure's shares are less volatile than average (for this exchange).
To put Intercure's beta into context you can compare it against those of similar companies.
InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. .
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.